Caplacizumab Antibody
Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor nanobody used in research to study thrombotic thrombocytopenic purpura (TTP) . It functions by inhibiting vWF-mediated platelet adhesion to prevent microthrombosis, with applications in both in vitro and in vivo experimental models of thrombotic disorders.
Product Specifications
Target
Integrin
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog